Logo image
Medicinal potential of ciprofloxacin and its derivatives
Journal article   Peer reviewed

Medicinal potential of ciprofloxacin and its derivatives

W. Castro, M. Navarro and C. Biot
Future Medicinal Chemistry, Vol.5(1), pp.81-96
2013
url
Link to Published Version *Subscription may be requiredView
url
Free to Read *No subscription requiredView

Abstract

Ciprofloxacin (CP) is a fluoroquinolone that is highly active against diverse microorganisms. At concentrations less than 1 g/ml it is active against a diverse types of bacteria, including Staphylococcus aureus, Staphylococcus epidermidis, Bacillius subtilius, Escherichia coli and Mycobacterium tuberculosis. In addition, it has shown to be effective against other diseases such as malaria, cancer and AIDS. The extended antimicrobial activity, lack of plasmid-mediated resistance, large volume of distribution and minimal adverse effects of CP are therapeutically advantageous. In the pursuit of increasing their effectiveness against these diseases and prevent unwanted resistance, researchers have begun to synthesize a class of organic, inorganic and organometallic derivatives, which have displayed interesting activities. This review describes the development and recent advances on the evaluation of CP and its derivatives as a new class of drugs with potential for clinical development.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.219 Cancer Drugs
1.219.1351 Topoisomerase Inhibitors
Web Of Science research areas
Chemistry, Medicinal
ESI research areas
Chemistry
Logo image